In a study recently published in the European Journal of Pharmacology researchers at Okayama University show h...
Researchers at Duke-NUS Medical School and their colleagues have identified a surprising interaction between dengue and ...
Analysis of genetic data from more than 94,000 individuals has revealed five new risk genes for Alzheimer’s diseas...
China based Adagene, Inc., an innovative antibody discovery and engineering company, has announced a multi-target platfo...
A team led by Dr. Chi-Huey Wong, Distinguished Research Fellow, Academia Sinica in Taiwan, in collaboration with OBI sci...
Chipscreen Biosciences, a leading integrated Chinese biotech company specialized in discovery and development of novel s...
Scientists from A*STAR’s Institute of Molecular and Cell Biology (IMCB) have discovered that niclosamide, an FDA-a...
Parkinson's disease (PD) is the second most common neurodegenerative disorder, implicating 10 million people worldwide b...
Researchers at Duke-NUS Medical School have demonstrated for the first time a physical interaction between two types of ...
Nanoparticles can be found in processed food (e.g. food additives), consumer products (e.g. sunscreen) and even in medic...
Hokkaido University researchers have developed a strategy to fabricate materials that become stronger in response to mec...
Alvotech has successfully raised US$300 million through a private bond offering. Net proceeds from the capital raised ...
A team of NUS researchers has developed a novel medical device capable of harnessing a magnetic field to make muscle reh...
China-based clinical stage biopharmaceutical company, I-Mab Biopharma, exclusively focused on the development of innovat...
The bone matrix contains various proteins, namely, collagen and other non-collagenous proteins. Osteoblasts are responsi...
Researchers at A*STAR's Singapore Bioimaging Consortium (SBIC) have discovered that branched-chain amino acids (BCAAs) i...
Ribon Therapeutics, a biotechnology company developing first-in-class therapeutics targeting novel enzyme families activ...
US based biotech company, Tizona Therapeutics has announced that Scott Clarke has joined the company as its chief execut...
